Singulex Announces Presentation on Monitoring of Cardiac Biomarker to Assess Transient Myocardial Ischemia at the American Heart Association Scientifi... ( ORLANDO Fla. Nov. 4 /- Singulex I...)

HOME >> MEDICINE >> NEWS

Singulex Announces Presentation on Monitoring of Cardiac Biomarker to Assess Transient Myocardial Ischemia at the American Heart Association Scientific Sessions

Date:11/4/2007

ORLANDO, Fla., Nov. 4 /PRNewswire/ -- Singulex Inc. announced today that its technology will be highlighted in an oral presentation (#3108) at the American Heart Association Scientific Sessions on Wednesday, November 7 at 11:15 a.m. in West F1. The presentation is entitled "Single Molecule Troponin Detection to Assess for Transient Myocardial Ischemia" by Marc Sabatine, M.D., M.P.H. and David Morrow, M.D., M.P.H.

Dr. Sabatine is an associate physician in the Cardiovascular Medicine Division at Brigham and Women's Hospital (BWH), an investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group, and an assistant professor of medicine at Harvard Medical School. Dr. Sabatine's research focuses on the diagnosis and treatment of acute coronary syndromes, with a particular interest in using biomarkers, genetic epidemiology, and proteomics for risk stratification. His research endeavors in those fields are supported by several grants from the National Institutes of Health. Dr. Sabatine has authored over 100 original research articles, reviews, editorials, and book chapters and serves as a manuscript reviewer for several major medical journals. Dr. Sabatine has been awarded a Howard Hughes Medical Institute Research Fellowship, an ACC Cardiology Fellowship, and the ACC Young Investigator Award. He is board certified in Internal Medicine and Cardiology and is a member of the American Heart Association and a Fellow of the American College of Cardiology.

Dr. Morrow is assistant professor of medicine at Harvard Medical School, in the division of cardiovascular medicine at BWH. He was instrumental in the development of the TIMI Biomarker Program at BWH, and his research at TIMI focuses on risk stratification and the management of acute coronary syndromes. Dr. Morrow sits on the National Academy of Clinical Biochemistry (NACB) Laboratory Medicine Practice Guidelines Committee on Biochemical Cardiac Markers and leads the clinical section on ACS. He
'/>"/>

SOURCE Singulex Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care

Post Your Comments:

(Date:12/4/2009)...e, MD "Why is it that men can be bastards and wo... Hecht Schafran. The answer, according to an artic...rpretation of facial expressions. , In two studi... of a series of faces. In the first study, androgy...ngry expressions) were more likely to be identifie...

(Date:12/4/2009)... exercise, water and fruit consumption leads to s... (HealthDay News) -- Increased exercise, reduced s...st effective weight control strategies for adolesc... 130 adolescents about their weight-control strate... in losing weight and 68 had not. The responses we...

(Date:12/4/2009)... , Dr. Redlener Applauds Historic Effort but P...rograms Are Lost in Final Health Care Reform ,... New England Journal of Medicine today publish...are reform, co-authored by Irwin Redlener, M.D., p...ional Center for Disaster Preparedness and Profess...

(Date:12/4/2009)...E Cholesterol-lowering drugs known as statins are...ow a new study by researchers at Fred Hutchinson C...rotect stem cell transplant patients from one of t...ancer therapy: graft-versus-host disease, or GVHD....tion of the journal Blood . , In a retrospective...

(Date:12/4/2009)...y found they spurred blood vessel growth after hea...News) -- Adult stem cells appear to help repair he...se 1 study of 53 patients found that stem cells fr...ood vessels in heart tissue damaged by heart attac...ions within 10 days of having a heart attack. Duri...

Breaking Medicine News(10 mins):Health News:Are angry women more like men? 2 Health News:Teens Lose More Weight Using Healthy Strategies 2 Health News:New England Journal of Medicine Perspective by Irwin Redlener, MD, Addresses Health Care Reform 2 Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2

[0] Are angry women more like men?[0] Teens Lose More Weight Using Healthy Strategies [0] New England Journal of Medicine Perspective by Irwin Redlener, MD, Addresses Health Care Reform [0] Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD [0] Adult Stem Cells Can Repair Damaged Heart

...ces,focused, corporate, investor and public relati...d as agency of record by Agile Therapeutics, of,Pr.... Donna LaVoie, President and CEO, commented, "La... with the venture,capital, biopharmaceutical and p...

...xpand Agency Representation in M...nover,Insurance Group, Inc. (NYSE: THG ), a leadi...Massachusetts, announced today that it has request...urrently available in the marketplace. (Logo: ht...

...-Quarters Say Governments, Should Look Beyond Econ...s, BRUSSELS, Belgium, Nov. 19 Three-quarters of,...should look beyond,economics, and include health, ... Around 1,000 respondents in each country were ask...

...aq: CRVL ) today announced its decision to resume... stock repurchase program previously approved,by t... Board had approved a,1,500,000 share expansion to...ed from time to time in the future under the,expan...

...no Inc.,and the Christian Doppler Laboratory for M...s-University in Graz today announced a scientific,.... The project will focus,on the application of flo...the Christian Doppler Research,Association (CDG) w...

...19 At its Board Meeting on Wednesday,November 14,...oved 11,grants for new research on topics ranging ...adults to interventions that reduce tobacco use an...rchers through these grants, which bring ClearWay,...

Other Medicine News:Health News:LaVoie Group Adds Two New Companies to Its Life Science Client Roster 2 Health News:The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off State's Existing Six-Year Surcharge Period 2 Health News:The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off State's Existing Six-Year Surcharge Period 3 Health News:The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off State's Existing Six-Year Surcharge Period 4 Health News:GLOBESCAN Survey for the BEYOND GDP Conference, European Parliament, Nov. 19th and 20th 2 Health News:GLOBESCAN Survey for the BEYOND GDP Conference, European Parliament, Nov. 19th and 20th 3 Health News:CorVel Corporation Announces Resumption of Stock Repurchases 2 Health News:CorVel Corporation Announces Resumption of Stock Repurchases 3 Health News:ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies 2 Health News:ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies 3 Health News:ClearWay Minnesota(SM) Board Approves $2.8 Million for Research Grants 2 Health News:ClearWay Minnesota(SM) Board Approves $2.8 Million for Research Grants 3

LaVoie Group Adds Two New Companies to Its Life Science Client Roster The Hanover Seeks to Cut Auto Rates by Up to 30 Percent or More; Shave Three Years Off State's Existing Six-Year Surcharge Period GLOBESCAN Survey for the BEYOND GDP Conference, European Parliament, Nov. 19th and 20th CorVel Corporation Announces Resumption of Stock Repurchases ThalesNano Inc. and the Christian Doppler Laboratory for Microwave Chemistry in Graz, Austria Collaborate on Flow Chemistry Technologies ClearWay Minnesota(SM) Board Approves $2.8 Million for Research Grants

(Date:12/4/2009)...Newswire/ -- Thermographic Diagnostic Imaging (TDI...on, New Jersey continues to provide superior quali...ystem, thyroid, dental, TMJ and sinus regions to a...d with these areas. ,, Thermography utilizes i...rared range of the electromagnetic spectrum and pr...

(Date:12/4/2009)... 4 Onyx Pharmaceuticals,...l host an investor teleconference and webcast. Pr...tations surrounding carfilzomib in relapsed and/or...1st American Society of Hematology (ASH) Annual Me... a.m. CT/10:00 a.m. ET on Monday, December 7, 2009...

(Date:12/4/2009)...RNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Am...l countermeasures against biological and chemical ...ata from the Company,s anthrax vaccine program sho...ntigen (rPA) based anthrax vaccine is structurally...eratures up to and including 55 degrees C. The da...

[0] Discover Health Through Awareness [0] Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference [0] PharmAthene Presents rPA Anthrax Vaccine Data at the 2009 HHS PHEMCE Stakeholders Workshop

...A-H-M-S,Aktiengesellschaft today announced it has ...ministration (FDA) to market its patented B-R-A-H-...ic Peptide (ANP) is predominantly produced in the ...uretic peptides in the,circulation. ANP is involve...ovascular homeostasis. Although this peptide is un...

...an autoimmune disease that leads to thickening and... failure of internal organs, including the lungs, ...h the Scleroderma Foundation estimates affects app...here is no cure. A major and incapacitating compli... on the patients, fingers and toes that are very p...

Other Medicine Technology:FDA Submission of B-R-A-H-M-S MR-proANP Kryptor 2 New Study Using Combination of Bioengineered Skin and Stem Cells Shows Promise in Treatment of Non-Healing Wounds 2 New Study Using Combination of Bioengineered Skin and Stem Cells Shows Promise in Treatment of Non-Healing Wounds 3

FDA Submission of B-R-A-H-M-S MR-proANP Kryptor New Study Using Combination of Bioengineered Skin and Stem Cells Shows Promise in Treatment of Non-Healing Wounds

Genesis II Femoral Instrumentation

MIS Tibial Stylus

Ascent Anterior Referencing Femoral Instrument Case

Ascent Knee System Case # 1

Medicine Products:

Genesis II Femoral Instrumentation MIS Tibial Stylus Ascent Anterior Referencing Femoral Instrument Case Ascent Knee System Case # 1

Singulex Announces Presentation on Monitoring of Cardiac Biomarker to Assess Transient Myocardial Ischemia at the American Heart Association Scientifi...( ORLANDO Fla. Nov. 4 /- Singulex I...),Health